Prostate cancer
Conditions
Interventions
Novel Urethral Fixation Technique group:Using the Novel Urethral Fixation Technique
Sponsors
The First Affiliated Hospitalof Chongqing Medical University
Eligibility
Sex/Gender
Male
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Middle aged and elderly males aged 40-75; 2. Pathological diagnosis of prostate cancer through puncture; 3. In good physical condition, without serious cardiovascular or pulmonary diseases, able to tolerate major urological surgeries under general anesthesia; 4. Organ localization assessed by whole-body bone scan (ECT), magnetic resonance imaging (MRI), and/or PSMAPET-CT 5. Localized progressive prostate cancer, evaluated as suitable for robot laparoscopic radical prostatectomy, with significant surgical benefits; 6. Normal preoperative urine flow rate with no residual urine, normal preoperative urination and urinary control function; 7. Patients who voluntarily accept the experimental plan and sign an informed consent form after informing them of the existing treatment plan.
Exclusion criteria
Exclusion criteria: 1. Patients with metastatic prostate cancer; 2. Patients with preoperative urinary incontinence or abnormal urinary control function; 3. Previously diagnosed with urethral stricture, bladder neck contracture, or urinary incontinence, having undergone urethral stricture incision or bladder neck contracture incision, or having an atonic or neurogenic bladder; 4. Patients who have undergone transurethral resection of the prostate, laser therapy, microwave therapy, radiofrequency ablation, or other prostate surgeries and pelvic radiation therapy before surgery; 5. Suffering from other serious systemic diseases that the researchers believe may interfere with the treatment, evaluation, and compliance of this trial, including severe respiratory, circulatory, neurological, psychiatric, digestive, endocrine, immune, urinary and other systemic diseases; 6. Patients who are deemed unsuitable by the researchers to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary continence recovery rate at one month after extubation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Urinary continence recovery rate at 1 week, 2 weeks, and 3 months after extubation;Accurate 24-hour urine leakage at 1 week, 2 weeks, 1 month, and 3 months after extubation;The effect of postoperative urinary continence recovery time and SFUR on postoperative urinary continence recovery time;Postoperative urinary function and quality of life related to urination;Postoperative positive margins and postoperative complications; | — |
Countries
China
Contacts
Public ContactChen Yong
The Department of Urology of The First Affiliated Hospitalof Chongqing Medical University
Outcome results
None listed